FDA Advisory No.2023-1569 || Product Recall of the Specific Batches of Piperacillin (as sodium) + Tazobactam (as sodium) 2g/250mg Powder for Injection (IV Infusion) [Piptaz], Piperacillin (as sodium) + Tazobactam (as sodium) 4g/500mg Powder for Injection (IV Infusion) [Piptaz], Co-Amoxiclav 600 mg Powder for Injection [Amoclav] and Co-Amoxiclav 1.2g Powder for Injection (I.V.) [Amoclav]

All healthcare professionals and the general public are hereby advised by the Food and Drug Administration (FDA) regarding the voluntary recall by the marketing authorization holder (MAH) on the affected […]